BCM
APYX icon

BlueCrest Capital Management’s Apyx Medical APYX Stock Holding History

BlueCrest Capital Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-31,990
Closed -$202K – 436
2019
Q1 		$202K Buy
31,990
+8,212
+35% +$63.5K 0.01% 945
2018
Q4 		$154K Buy
+23,778
New +$144K 0.01% 709

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlueCrest Capital Management's APYX Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Apyx Medical (APYX) in Q2 2019, closing a stake of 31,990 shares — an estimated $202K sold.

BlueCrest Capital Management first reported a position in APYX in Q4 2018 and held it in 2 quarters. The position peaked at $202K in Q1 2019. 66 funds tracked by Wall St. Rank hold APYX as of Q2 2019.

  • BlueCrest Capital Management reported no remaining Apyx Medical position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 31,990 Apyx Medical shares in Q2 2019, an estimated $202K.
  • BlueCrest Capital Management first reported a position in Apyx Medical in Q4 2018 and held it in 2 quarters.
  • BlueCrest Capital Management's Apyx Medical position peaked at $202K in Q1 2019.
  • 66 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.